# Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer

> **NCT02679911** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 20 (actual)

## Conditions studied

- Foot Dermatoses

## Interventions

- **DRUG:** Loceryl NL
- **DRUG:** Ciclopirox NL

## Key facts

- **NCT ID:** NCT02679911
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02679911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02679911, "Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02679911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*